BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38579174)

  • 21. Clinical significance and biological function of WD repeat domain 54 as an oncogene in colorectal cancer.
    Yuan Y; Qi G; Shen H; Guo A; Cao F; Zhu Y; Xiao C; Chang W; Zheng S
    Int J Cancer; 2019 Apr; 144(7):1584-1595. PubMed ID: 29987896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated expression of minichromosome maintenance 3 indicates poor outcomes and promotes G1/S cell cycle progression, proliferation, migration and invasion in colorectal cancer.
    Zhou H; Xiong Y; Zhang G; Liu Z; Li L; Hou S; Zhou T
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32597491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pan-Cancer analysis and experimental validation identify the oncogenic nature of ESPL1: Potential therapeutic target in colorectal cancer.
    Zhong Y; Zheng C; Zhang W; Wu H; Wang M; Zhang Q; Feng H; Wang G
    Front Immunol; 2023; 14():1138077. PubMed ID: 37006282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. KH-Type Splicing Regulatory Protein Controls Colorectal Cancer Cell Growth and Modulates the Tumor Microenvironment.
    Caiazza F; Oficjalska K; Tosetto M; Phelan JJ; Noonan S; Martin P; Killick K; Breen L; O'Neill F; Nolan B; Furney S; Power R; Fennelly D; Craik CS; O'Sullivan J; Sheahan K; Doherty GA; Ryan EJ
    Am J Pathol; 2019 Oct; 189(10):1916-1932. PubMed ID: 31404541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
    Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X
    Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Organoid modelling identifies that DACH1 functions as a tumour promoter in colorectal cancer by modulating BMP signalling.
    Hu X; Zhang L; Li Y; Ma X; Dai W; Gao X; Rao X; Fu G; Wang R; Pan M; Guo Q; Xu X; Zhou Y; Gao J; Zhang Z; Cai S; Peng J; Hua G
    EBioMedicine; 2020 Jun; 56():102800. PubMed ID: 32512510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PDCD6 cooperates with C-Raf to facilitate colorectal cancer progression via Raf/MEK/ERK activation.
    Wang X; Wu F; Wang H; Duan X; Huang R; Tuersuntuoheti A; Su L; Yan S; Zhao Y; Lu Y; Li K; Yao J; Luo Z; Guo L; Liu J; Chen X; Lu Y; Hu H; Li X; Bao M; Bi X; Du B; Miao S; Cai J; Wang L; Zhou H; Ying J; Song W; Zhao H
    J Exp Clin Cancer Res; 2020 Aug; 39(1):147. PubMed ID: 32746883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IDO1 and Kynurenine Pathway Metabolites Activate PI3K-Akt Signaling in the Neoplastic Colon Epithelium to Promote Cancer Cell Proliferation and Inhibit Apoptosis.
    Bishnupuri KS; Alvarado DM; Khouri AN; Shabsovich M; Chen B; Dieckgraefe BK; Ciorba MA
    Cancer Res; 2019 Mar; 79(6):1138-1150. PubMed ID: 30679179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pan-cancer analysis of PCAT6 and its effect on oesophageal squamous cell carcinoma cell proliferation and migration.
    Luo Q; Kuang Y; Tao X; Zhu X; Zhao X; Lu G; Zhang W; Sun E; Chen B
    Med Oncol; 2023 Mar; 40(4):125. PubMed ID: 36949349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DDX3 as a strongest prognosis marker and its downregulation promotes metastasis in colorectal cancer.
    Su CY; Lin TC; Lin YF; Chen MH; Lee CH; Wang HY; Lee YC; Liu YP; Chen CL; Hsiao M
    Oncotarget; 2015 Jul; 6(21):18602-12. PubMed ID: 26087195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated OCT1 participates in colon tumorigenesis and independently predicts poor prognoses of colorectal cancer patients.
    Wang YP; Song GH; Chen J; Xiao C; Li C; Zhong L; Sun X; Wang ZW; Deng GL; Yu FD; Xue YM; Tang HM; Peng ZH; Wang XL
    Tumour Biol; 2016 Mar; 37(3):3247-55. PubMed ID: 26433389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Large tumor suppressor 2 is a prognostic biomarker and correlated with immune infiltrates in colorectal cancer.
    Zhao C; Chen J; Liu Y; Ju S; Wang G; Wang X
    Bioengineered; 2021 Dec; 12(2):11648-11661. PubMed ID: 34699318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metalloproteases meprin-ɑ (MEP1A) is a prognostic biomarker and promotes proliferation and invasion of colorectal cancer.
    Wang X; Chen J; Wang J; Yu F; Zhao S; Zhang Y; Tang H; Peng Z
    BMC Cancer; 2016 Jul; 16():383. PubMed ID: 27378469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PDRG1 predicts a poor prognosis and facilitates the proliferation and metastasis of colorectal cancer.
    Xu Y; Liu J; Jiang T; Shi L; Shang L; Song J; Li L
    Exp Cell Res; 2021 Dec; 409(2):112924. PubMed ID: 34780783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
    Wang D; Fu L; Sun H; Guo L; DuBois RN
    Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Jumonji domain containing 1A is a novel prognostic marker for colorectal cancer: in vivo identification from hypoxic tumor cells.
    Uemura M; Yamamoto H; Takemasa I; Mimori K; Hemmi H; Mizushima T; Ikeda M; Sekimoto M; Matsuura N; Doki Y; Mori M
    Clin Cancer Res; 2010 Sep; 16(18):4636-46. PubMed ID: 20823141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Forkhead‑box A1 regulates tumor cell growth and predicts prognosis in colorectal cancer.
    Park YL; Kim SH; Park SY; Jung MW; Ha SY; Choi JH; Myung DS; Cho SB; Lee WS; Kim HS; Joo YE
    Int J Oncol; 2019 Jun; 54(6):2169-2178. PubMed ID: 31081047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of biomarkers related to Tumor-Infiltrating Lymphocytes (TILs) infiltration with gene co-expression network in colorectal cancer.
    Liao R; Ma QZ; Zhou CY; Li JJ; Weng NN; Yang Y; Zhu Q
    Bioengineered; 2021 Dec; 12(1):1676-1688. PubMed ID: 33960283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ID4 predicts poor prognosis and promotes BDNF-mediated oncogenesis of colorectal cancer.
    Ha CT; Cheng CY; Zheng MY; Hsu TH; Miao CC; Lee CJ; Wang HD; Pan ST; Chou YT
    Carcinogenesis; 2021 Jul; 42(7):951-960. PubMed ID: 33993270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High expression of fibronectin is associated with poor prognosis, cell proliferation and malignancy via the NF-κB/p53-apoptosis signaling pathway in colorectal cancer.
    Yi W; Xiao E; Ding R; Luo P; Yang Y
    Oncol Rep; 2016 Dec; 36(6):3145-3153. PubMed ID: 27748871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.